Compound repurposing
Small molecule compounds are being studied for repurposing in COVID-19 treament and research. Multiple small molecules that are approved to treat other disorders have shown potential effects on key proteins involved in SARS-CoV-2 host cell entry and replication. Repurposing of existing compounds is advantageous for speed - reducing timescales compared to conventional drug discovery. Researchers can save up to 50% on these small molecules for COVID-19 research, as they are up to half the price of other suppliers.
Acridine Orange hydrochloride (HB0699)
Description:Cell permeable fluorescent nucleic acid binding dye
BrdU (5-Bromo-2′-deoxyuridine) (HB0979)
Description:Thymidine analog. Widely used to identify proliferating cells, enhances Yamanaka factor reprogramming
Purity:>98%
H2DCFDA (HB8322)
Description:Fluorescent dye for ROS and oxidative stress detection. Used to measure redox state of a cell.
Hoechst 33342 (HB0787)
Description:Blue fluorescent DNA stain. Cell permeable. Nuclear stain.
Purity:>98%
- Description:
Blue fluorescent DNA stain. Nuclear stain. 10mg/ml staining solution in water. Solid also available in 50mg and 100mg.
JC-1 (HB0791)
Description:Mitochondrial membrane potential indicator/dye. Widely used in apoptosis studies.
Purity:>95%